StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -217.3%, against -138.8% the year before. The highest annual figure on record is -74.0% in fiscal 2023.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-217.3%−78.5
FY2024Dec 31, 2024-138.8%−64.8
FY2023Dec 31, 2023-74.0%+4.9
FY2022Dec 31, 2022-78.9%+58.7
FY2021Dec 31, 2021-137.6%+211.0
FY2020Dec 31, 2020-348.6%–

More CASI Pharmaceuticals figures

See a number that looks wrong?